Literature DB >> 14211467

PRIMARY DRUG RESISTANCE IN TUBERCULOSIS.

G CANETTI, N RIST, J GROSSET.   

Abstract

Entities:  

Keywords:  ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MICROBIAL; MYCOBACTERIUM TUBERCULOSIS; PHARMACOLOGY; TUBERCULOSIS

Mesh：

Substances：

Year:  1964        PMID： 14211467     DOI： 10.1164/arrd.1964.90.5.792

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  6 in total

1.  The prevalence in Canada of drug-resistant tubercle bacilli in newly discovered untreated patients with tuberculosis.

Authors:  A R Armstrong
Journal:  Can Med Assoc J       Date:  1966-02-26       Impact factor: 8.262

2.  Use of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide for rapid detection of rifampin-resistant Mycobacterium tuberculosis.

Authors:  R N Mshana; G Tadesse; G Abate; H Miörner
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

3.  The trend of infection with drug-resistant strains of Mycobacterium tuberculosis among untreated patients. I. Isoniazid.

Authors:  M H Zaki; H A Lyons; R Tizes; F Godinez
Journal:  Am J Public Health Nations Health       Date:  1969-11

4.  Processing sputum specimens in a refrigerated centrifuge does not increase the rate of isolation of Mycobacterium tuberculosis.

Authors:  N Selvakumar; Dakshayani Govindan; Naik Ashok Chandu; Thomas R Frieden; P R Narayanan
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

5.  Determination of drug resistance of Mycobacterium tuberculosis cultures.

Authors:  V Montalbine; F M Collins
Journal:  Appl Microbiol       Date:  1971-04

6.  Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli.

Authors:  R M McCune; F M Feldmann; W McDermott
Journal:  J Exp Med       Date:  1966-03-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.